These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12431237)

  • 1. Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22).
    Seftel MD; Bruyere H; Copland M; Hogge DE; Horsman DE; Nantel SH; Shepherd JD; Lavoie JC; Le A; Sutherland HJ; Toze CL; Nevill TJ
    Eur J Haematol; 2002 Oct; 69(4):193-9. PubMed ID: 12431237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute myelogenous leukemia complicated with severe tumor lysis syndrome after a single day of idarubicin/cytarabine chemotherapy].
    Kikuchi T; Miyata A; Fujii S; Kikuchi T
    Rinsho Ketsueki; 2003 Nov; 44(11):1113-6. PubMed ID: 14689878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults.
    Min GJ; Kim HJ; Yoon JH; Kwak DH; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1621-1628. PubMed ID: 29698793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute myelomonocytic leukemia with inv (16) (p13 q22) disappeared abnormal karyotype during complete remission].
    Tsushima Y; Yukita T; Mikami T; Takami H; Aihara M; Kawamura S; Yoshida Y; Chiba Y
    Rinsho Ketsueki; 1989 Dec; 30(12):2178-82. PubMed ID: 2621800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
    Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
    Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent molecular remission of refractory acute myeloid leukemia with inv(16)(p13.1q22) in an elderly patient induced by cytarabine ocfosfate hydrate.
    Arahata M; Shimizu Y; Asakura H; Nakao S
    J Hematol Oncol; 2015 Feb; 8():5. PubMed ID: 25652695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of myeloperoxidase containing blast cells in acute myelogenous leukaemia.
    Advani SH; Hegde UP; Iyer RS; Gopal R; Saikia TK; Pai SK; Nair CN; Kurkure PA; Pai VR; Nadkarni KS
    Indian J Med Res; 1993 Feb; 98():8-14. PubMed ID: 8388366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid blastic crisis of chronic myelogenous leukaemia with inv(16)(p13;q22).
    Tsuboi K; Komatsu H; Miwa H; Iida S; Banno S; Wakita A; Nitta M; Ueda R
    Leuk Res; 2002 Aug; 26(8):771-4. PubMed ID: 12191573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literature.
    Betts DR; Rohatiner AZ; Evans ML; Rassam SM; Lister TA; Gibbons B
    Leukemia; 1992 Dec; 6(12):1250-6. PubMed ID: 1453770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse alveolar hemorrhage during induction therapy for acute myeloid leukemia with inv(16)(p13.1q22).
    Kanaya M; Kondo T
    Int J Hematol; 2020 Aug; 112(2):134-135. PubMed ID: 32506319
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia.
    Eghtedar A; Borthakur G; Ravandi F; Jabbour E; Cortes J; Pierce S; Kantarjian H; Garcia-Manero G
    Am J Hematol; 2012 Mar; 87(3):317-8. PubMed ID: 22228403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
    Quesnel B; Kantarjian H; Bjergaard JP; Brault P; Estey E; Lai JL; Tilly H; Stoppa AM; Archimbaud E; Harousseau JL
    J Clin Oncol; 1993 Dec; 11(12):2370-9. PubMed ID: 8246025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinoside.
    Ghaddar HM; Plunkett W; Kantarjian HM; Pierce S; Freireich EJ; Keating MJ; Estey EH
    Leukemia; 1994 Aug; 8(8):1269-74. PubMed ID: 8057660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16)(p13q22)].
    Kumagawa M; Suzuki K; Nagano M; Takamatsu Y; Suzumiya J; Tamura K
    Rinsho Ketsueki; 2003 Jun; 44(6):404-6. PubMed ID: 12884821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia].
    Taguchi H; Kubonishi I; Takehara N; Uemura Y; Iwahara Y; Eguchi T; Miyagi T; Sugito S; Muneishi H; Tanaka Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1309-14. PubMed ID: 1503485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A predictive model for the detection of tumor lysis syndrome during AML induction therapy.
    Mato AR; Riccio BE; Qin L; Heitjan DF; Carroll M; Loren A; Porter DL; Perl A; Stadtmauer E; Tsai D; Gewirtz A; Luger SM
    Leuk Lymphoma; 2006 May; 47(5):877-83. PubMed ID: 16753873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous intravenous administration of daunorubicin and cytarabine for remission induction of poor risk acute myelogenous leukaemias and myelodysplastic syndromes.
    Bär BM; de Witte T; de Pauw BE; Haanen C
    Neth J Med; 1990 Feb; 36(1-2):19-24. PubMed ID: 2314517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature.
    Zhang XH; Zhang R; Li Y
    Leuk Res; 2010 Jul; 34(7):958-61. PubMed ID: 20116851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults.
    Kornblau SM; Gandhi V; Andreeff HM; Beran M; Kantarjian HM; Koller CA; O'Brien S; Plunkett W; Estey E
    Leukemia; 1996 Oct; 10(10):1563-9. PubMed ID: 8847890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.